Biotech firm Asylia Therapeutics raises $14.5M, names founding CEO
May 25, 2021 at 14:03 PM EDT
Proceeds from the Series A will go toward furthering Asylia's pipeline of assets in clinical trials, the firm said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|